PubMed · 2014 · 12 citations · 7 references
MedicineHematologyOncologyChemotherapyHematologic OncologyOncology PharmacotherapyChemotherapy In Hematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyLymphoid NeoplasmsLymphoid TumorsLymphoma ImagingChemotherapy Administration In LymphomaIntrathecal AdministrationIntravascular Large B-cell LymphomaLymphoma ChemotherapyRituximab-based Therapy
A 46-year-old man developed a fever and cough, and computed tomography showed multiple, nodular infiltrative shadows in lungs. He was diagnosed as having intravascular large B-cell lymphoma (IVLBCL). Brain magnetic resonance imaging (MRI, T2W1) showed an abnormal signal area in the pons, which was IVLBCL involvement. R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) therapy and intrathecal (I.T.) injection of methotrexate, cytarabine and prednisolone were selected. Complete remission (CR) was achieved and pontine involvement disappeared. A total of 8 courses of R-CHOP therapy and 4 courses of I.T. were performed. CR has been maintained for 1 year and 2 months.
7
Jorge Romaguera, Luis Fayad, Maria Alma Rodriguez et al. · Journal of Clinical Oncology · 2005 · 559 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Kazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto et al. · Journal of Clinical Oncology · 2008 · 277 citations
Medicine, Oncology, Pharmacotherapy +14